The role of probiotics in prevention and treatment for patients with allergic rhinitis: A systematic review

American Journal of Rhinology and Allergy

Volumn 29, Issue 4, 2015, Pages 292-298

  Peng, Yi ^a   Li, Ailing ^b   Yu, Ling ^a   Qin, Gang ^a  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE OLIGOSACCHARIDE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; YOGHURT;

ALLERGIC RHINITIS; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA BASE; DATA SYNTHESIS; DRUG EFFICACY; EMBASE; HUMAN; IMMUNOLOGICAL PARAMETERS; MEDLINE; META ANALYSIS; NASAL SYMPTOM SCORE; NOSE DISEASE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; META ANALYSIS (TOPIC); RHINITIS, ALLERGIC;

HUMANS; META-ANALYSIS AS TOPIC; PROBIOTICS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC; TREATMENT OUTCOME;

EID: 84944035873     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2015.29.4192     Document Type: Review

References (48)

1. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 126:466-476, 2010.
2. Small P, and Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol 7(suppl. 1):S3, 2011.
3. Christodoulopoulos P, Cameron L, Durham S, et al. Molecular pathology of allergic disease. II: Upper airway disease. J Allergy Clin Immunol 105:211-223, 2000.
4. Björkstén B. The intrauterine and postnatal environments. J Allergy Clin Immunol 104: 1119-1127, 1999.
5. Blaser MJ, and Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 7:887-894, 2009.
6. Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336: 489-493, 2012.
7. Ouwehand AC, Nermes M, Collado MC, et al. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 15:3261-3268, 2009.
8. Ishida Y, Bandou I, Kanzato H, et al. Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Biosci Biotechnol Biochem 67:951-957, 2003.
9. Sivaprasad S, Bunce C, and Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev 2:CD004239, 2012.
10. Lue KH, Sun HL, Lu KH, et al. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years. Int J Pediatr Otorhinolaryngol 76:994-1001, 2012.
11. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119:1019-1021, 2007.
12. Helin T, Haahtela S, and Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: A placebo-controlled double-blind study. Allergy 57:243-246, 2002.
13. Kukkonen AK, Kuitunen M, Savilahti E, et al. Airway inflammation in probiotic-treated children at 5 years. Pediatr Allergy Immunol 22:249-251, 2011.
14. Kuitunen M, Kukkonen AK, Juntunen-Backman AK, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 123:335-341, 2009.
15. West CE, Hammarstrom ML, and Hernell O. Probiotics in primary prevention of allergic disease-follow-up at 8-9 years of age. Allergy 68:1015-1020, 2013.
16. Kalliomäki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet 361:1869-1871, 2003.
17. Dotterud CK, Storrø O, Johnsen R, et al. Probiotics in pregnant women to prevent allergic disease: A randomized, double-blind trial. Br J Dermatol 163:616-623, 2010.
18. Xiao JZ, Kondo S, Yanagisawa N, et al. Effect of probiotic Bifidobacterium longum BBS36 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo controlled trial. J Investig Allergol Clin Immunol 16:86-93, 2006.
19. Wang MF, Lin HC, Wang YY, et al. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 15:152-158, 2004.
20. Peng GC, and Hsu CH. The efficacy and safety of heat-killed Lacto-bacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 16:433-438, 2005.
21. Xiao JZ, Kondo S, Yanagisawa N, et al. Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial. Clin Exp Allergy 36:1425-1435, 2006.
22. Nagata Y, Yoshida M, Kitazawa H, et al Improvements in seasonal allergic disease with Lactobacillus plantarum no. 14. Biosci Biotechnol Biochem 74:1869-1877, 2010.
23. Ishida Y, Nakamura F, Kanzato H, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: A doubleblind, placebo-controlled study. J Dairy Sci 88:527-533, 2005.
24. Goldin BR, and Gorbach SL. Clinical indications for probiotics: an overview. Clin Infect Dis 46(suppl. 2):S96-S100; discussion S144-S151, 2008.
25. Malin M, Verronen P, Korhonen H, et al. Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms. Inflammopharmacology 5:219-236, 1997.
26. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 32:141-144, 1992.
27. Pessi T, Isolauri E, Sutas Y, et al. Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. Int Immunopharmacol 1:211-218, 2001.
28. Heller F, and Duchmann R. Intestinal flora and mucosal immune responses. Int J Med Microbiol 293:77-86, 2003.
29. Sudo N, Sawamura SA, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159:1739-1745, 1997.
30. Niers LE, Hoekstra MO, Timmerman HM, et al. Selection of probiotic bacteria for prevention of allergic diseases: Immunomodulation of neonatal dendritic cells. Clin Exp Immunol 149:344-352, 2007.
31. Özdemir Ö. Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clin Exp Immunol 160:295-304, 2010.
32. Feleszko W, Jaworska J, Rha RD, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 37:498-505, 2007.
33. Ciprandi G, Vizzaccaro A, Cirillo I, et al. Bacillus clausii effects in children with allergic rhinitis. Allergy 60:702-710, 2005.
34. Lin TY, Chen CJ, Chen LK, et al. Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: A randomized double blind controlled trial. Indian Pediatr 50:209-213, 2013.
35. Gotoh M, Sashihara T, Ikegami S, et al. Efficacy of oral administration of a heat-killed Lactobacillus gasseri OLL2809 on patients of Japanese cedar pollinosis with high Japanese-cedar pollen-specific IgE. Biosci Biotechnol Biochem 73:1971-1977, 2009.
36. Ivory K, Chambers SJ, Pin C, et al. Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 38:1282-1289, 2008.
37. Wassenberg J, Nutten S, Audran R, et al. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy 41:565-573, 2011.
38. Chen YS, Jan RL, Lin YL, et al. Randomized placebo-controlled trial of Lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol 45:1111-1120, 2010.
39. Kawase M, He F, Kubota A, et al. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a doubleblind placebo-controlled clinical study. Int J Food Microbiol 128:429-434, 2009.
40. Singh A, Hacini-Rachinel F, Gosoniu M, et al. Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: An exploratory, randomized, placebocontrolled clinical trial. Eur J Clin Nutr 67:161-167, 2013.
41. Barnetson RSC, and Rogers M. Childhood atopic eczema. BMJ 324: 1376-1379, 2002.
42. Kim HJ, Kim HY, Lee SY, et al. Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J Pediatr 56:369-376, 2013.
43. Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis a meta-analysis. Epidemiology 23:402-414, 2012.
44. Ouwehand AC. Antiallergic effects of probiotics. J Nutr 137:794S-797S, 2007.
45. Hellman L. Regulation of IgE homeostasis, and the identification of potential targets for therapeutic intervention. Biomed Pharmacother 61:34-49, 2007.
46. Lin TY, Chen CJ, Chen LK, et al. Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: A randomized double blind controlled trial. Indian Pediatr 50:209-213, 2013.
47. Ishida Y, Nakamura F, Kanzato H, et al. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: A randomized placebo-controlled trial. Biosci Biotechnol Biochem 69:1652-1660, 2005.
48. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343:d5928, 2011.